×

Uh-oh, it looks like your Internet Explorer is out of date.

For a better shopping experience, please upgrade now.

Current Good Manufacturing Practices
     

Current Good Manufacturing Practices

by Mindy J. Allport-Settle
 
FDA Regulations and Associated Guidance Documents:
- Part 11 Electronic Records; Electronic Signatures
- Part 26 Mutual Recognition of Pharmaceutical Good Manufacturing Practice Reports, Medical Device Quality System Audit Reports, and Certain Medical Device Product Evaluation Reports: United States and the European Community
- Part 200 Drugs

Overview

FDA Regulations and Associated Guidance Documents:
- Part 11 Electronic Records; Electronic Signatures
- Part 26 Mutual Recognition of Pharmaceutical Good Manufacturing Practice Reports, Medical Device Quality System Audit Reports, and Certain Medical Device Product Evaluation Reports: United States and the European Community
- Part 200 Drugs General
- Part 207 Registration of Producers of Drugs and Listing of Drugs in Commercial Distribution
- Part 210 Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs
- Part 211 Current Good Manufacturing Practice For Finished Pharmaceuticals
- Part 600 Biological Products: General
- Part 807 Establishment Registration and Device Listing for Manufacturers and Initial Importers of Devices
- Part 820 Quality System Regulation

Reference Tools:

- Glossaries combined in one location
- GMP Keyword Index for 21CFR211
- Combined Index for all documents

Product Details

ISBN-13:
9781449505233
Publisher:
CreateSpace Publishing
Publication date:
09/17/2009
Pages:
634
Sales rank:
869,460
Product dimensions:
6.00(w) x 9.00(h) x 1.28(d)

Meet the Author

Mindy Allport-Settle has served as a key executive, board member, and consultant for some of the best companies in the pharmaceutical and FDA-regulated industry. Since joining PharmaLogika as CEO in 2008 and over her career, she has provided informed guidance in regulatory compliance, corporate structuring, restructuring and turnarounds, new drug submissions, research & development and product commercialization strategies, operational, project and contract management, and new business development. Her experience and dedication have resulted in international recognition as the developer of the only FDA-recognized and benchmarked quality systems training and development business methodology designed for regulated industries. Her education includes a Bachelor's degree from the University of North Carolina, an MBA in Global Management from the University of Phoenix, and completion of the corporate governance course series in audit committees, compensation committees, and board effectiveness at Harvard Business School.

Customer Reviews

Average Review:

Post to your social network

     

Most Helpful Customer Reviews

See all customer reviews